Literature DB >> 17616391

In CEM cells the autosomal deafness gene dfna5 is regulated by glucocorticoids and forskolin.

M S Webb1, A L Miller, E Brad Thompson.   

Abstract

Certain mutations of the dfna5 gene result in a form of autosomal deafness that holds special interest because its phenotype resembles the hearing loss often seen during aging. Little is known of the function or regulation of dfna5 or its encoded protein. However dfna5 has recently been shown to be induced by p53. It also is epigenetically repressed in gastric cancer. We have discovered that dfna5 can be induced by glucocorticoids (GCs) and that this regulation is influenced by crosstalk with the protein kinase A (PKA) system. We show that GCs induce dfna5 mRNA and that its expression appears to be repressed in the basal state. Induction of dfna5 mRNA correlates with GC-dependent apoptosis of CEM cells, though dfna5 expression alone is not sufficient for apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616391      PMCID: PMC2695606          DOI: 10.1016/j.jsbmb.2007.02.004

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  27 in total

1.  The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage.

Authors:  Yoshiko Masuda; Manabu Futamura; Hiroki Kamino; Yasuyuki Nakamura; Noriaki Kitamura; Shiho Ohnishi; Yuji Miyamoto; Hitoshi Ichikawa; Tsutomu Ohta; Misao Ohki; Tohru Kiyono; Hiroshi Egami; Hideo Baba; Hirofumi Arakawa
Journal:  J Hum Genet       Date:  2006-08-02       Impact factor: 3.172

2.  Glucocorticoid receptor and nuclear factor-kappa B interactions in restraint stress-mediated protection against acoustic trauma.

Authors:  Yeasmin Tahera; Inna Meltser; Peter Johansson; Anita C Hansson; Barbara Canlon
Journal:  Endocrinology       Date:  2006-06-15       Impact factor: 4.736

3.  Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss.

Authors:  F Van Wijk; H Staecker; E Keithley; P P Lefebvre
Journal:  Audiol Neurootol       Date:  2006-09-21       Impact factor: 1.854

4.  Refined mapping of a gene for autosomal dominant progressive sensorineural hearing loss (DFNA5) to a 2-cM region, and exclusion of a candidate gene that is expressed in the cochlea.

Authors:  L Van Laer; G Van Camp; D van Zuijlen; E D Green; M Verstreken; I Schatteman; P Van de Heyning; W Balemans; P Coucke; J H Greinwald; R J Smith; E Huizing; P Willems
Journal:  Eur J Hum Genet       Date:  1997 Nov-Dec       Impact factor: 4.246

5.  Receptors for glucocorticoids in the human inner ear.

Authors:  K E Rarey; L M Curtis
Journal:  Otolaryngol Head Neck Surg       Date:  1996-07       Impact factor: 3.497

6.  Lesion-induced plasticity in rat vestibular nucleus neurones dependent on glucocorticoid receptor activation.

Authors:  S A Cameron; M B Dutia
Journal:  J Physiol       Date:  1999-07-01       Impact factor: 5.182

7.  Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer.

Authors:  Kimishige Akino; Minoru Toyota; Hiromu Suzuki; Takashi Imai; Reo Maruyama; Masanobu Kusano; Noriko Nishikawa; Yoshiyuki Watanabe; Yasushi Sasaki; Tamaki Abe; Eiichiro Yamamoto; Isao Tarasawa; Tomoko Sonoda; Mitsuru Mori; Kohzoh Imai; Yasuhisa Shinomura; Takashi Tokino
Journal:  Cancer Sci       Date:  2007-01       Impact factor: 6.716

8.  Characterization of a gene that is inversely correlated with estrogen receptor expression (ICERE-1) in breast carcinomas.

Authors:  D A Thompson; R J Weigel
Journal:  Eur J Biochem       Date:  1998-02-15

9.  Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.

Authors:  R D Medh; M F Saeed; B H Johnson; E B Thompson
Journal:  Cancer Res       Date:  1998-08-15       Impact factor: 12.701

10.  Nonsyndromic hearing impairment is associated with a mutation in DFNA5.

Authors:  L Van Laer; E H Huizing; M Verstreken; D van Zuijlen; J G Wauters; P J Bossuyt; P Van de Heyning; W T McGuirt; R J Smith; P J Willems; P K Legan; G P Richardson; G Van Camp
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

View more
  8 in total

1.  An Integrated Bioinformatics and Computational Biology Approach Identifies New BH3-Only Protein Candidates.

Authors:  Robert G Hawley; Yuzhong Chen; Irene Riz; Chen Zeng
Journal:  Open Biol J       Date:  2012-05-04

2.  The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing protein.

Authors:  Ken Op de Beeck; Guy Van Camp; Sofie Thys; Nathalie Cools; Isabelle Callebaut; Karen Vrijens; Luc Van Nassauw; Viggo F I Van Tendeloo; Jean Pierre Timmermans; Lut Van Laer
Journal:  Eur J Hum Genet       Date:  2011-04-27       Impact factor: 4.246

Review 3.  Role of gasdermin family proteins in the occurrence and progression of hepatocellular carcinoma.

Authors:  Yandong Miao; Yonggang Chen; Denghai Mi
Journal:  Heliyon       Date:  2022-10-10

Review 4.  Lighting a Fire: Can We Harness Pyroptosis to Ignite Antitumor Immunity?

Authors:  Zhibin Zhang; Ying Zhang; Judy Lieberman
Journal:  Cancer Immunol Res       Date:  2021-01       Impact factor: 12.020

5.  Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation.

Authors:  Corey Rogers; Dan A Erkes; Alexandria Nardone; Andrew E Aplin; Teresa Fernandes-Alnemri; Emad S Alnemri
Journal:  Nat Commun       Date:  2019-04-11       Impact factor: 14.919

Review 6.  Biological Functions of Gasdermins in Cancer: From Molecular Mechanisms to Therapeutic Potential.

Authors:  Man Wang; Xinzhe Chen; Yuan Zhang
Journal:  Front Cell Dev Biol       Date:  2021-02-09

Review 7.  Gasdermin E: A Prospective Target for Therapy of Diseases.

Authors:  Xiu-Xiu Liao; Yong-Zhao Dai; Yao-Zhong Zhao; Ke Nie
Journal:  Front Pharmacol       Date:  2022-04-06       Impact factor: 5.988

Review 8.  Channelling inflammation: gasdermins in physiology and disease.

Authors:  Xing Liu; Shiyu Xia; Zhibin Zhang; Hao Wu; Judy Lieberman
Journal:  Nat Rev Drug Discov       Date:  2021-03-10       Impact factor: 112.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.